Clinical Trials Browser

Phase 1/2 × peginterferon alfa-2b × Clear all

NCT02089685 2022-09-13

MK-3475-029

Phase 1/2 Completed

295 enrolled 25 charts

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT02379195 2020-01-22

Peginterferon and TIL Therapy for Metastatic Melanoma

Phase 1/2 Completed

12 enrolled 10 charts

Melanoma

NCT00522249 2016-03-17

Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC

Phase 1/2 Terminated

Carcinoma, Renal Cell